DNR pulse treatment of primary AML
Ontology highlight
ABSTRACT: Primary human AML bone marrow sample (newly diagnosed, prior to treatment initation) was obtained from donor after consent and AML blasts were isolated by standard Ficoll centrifugation. AML blasts were pulse-treated with daunorubicine (100 nM, 200 nM, 400 nM) or DMSO control for 1 hour, followed by wash-out and short-term cell culture to allow cellular responses to develop. 20,000 cells were analysed by LC-MS3, and 5,000 cells were subjected to flow cytometry apoptosis assay.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Leukocyte, Blood
DISEASE(S): Acute Leukemia
SUBMITTER: Sebastian Koschade
LAB HEAD: Christian Muench
PROVIDER: PXD030280 | Pride | 2022-10-15
REPOSITORIES: Pride
ACCESS DATA